Yanghua Tian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yanghua Tian has a total of 773 co-authors. Here are the top co-authors by number of shared publications:
- Kai Wang
Department of Neurology, the First Affiliated Hospital of Anhui Medical University, Hefei 230032, China
88 shared publications Kai Wang
Department of Neurology, the First Affiliated Hospital of Anhui Medical University, Hefei, China
56 shared publicationsTongjian Bai
Department of Neurology, the First Affiliated Hospital of Anhui Medical University, 218 Jixi Rd, Hefei, 230022, China
41 shared publicationsQiang Wei
Department of Neurology, the First Affiliated Hospital of Anhui Medical University, Hefei, China
40 shared publications- Gong-Jun Ji
School of Mental Health and Psychological Sciences, Anhui Medical University, Hefei, China
27 shared publications Panpan Hu
Department of Neurology, The First Affiliated Hospital of Anhui Medical University, He Fei 230022, China; Collaborative Innovation Center of Neuropsychiatric Disorders and Mental Health, Hefei 230032, China; Anhui Province Key Laboratory of Cognition and Neuropsychiatric Disorders, Hefei 230032, China
23 shared publications
Latest Publications
- Open Access
- 4 November 2026
- Published by Springer Nature in Child and Adolescent Psychiatry and Mental Health
Local neural synchrony and suicidal ideation severity in adolescents with non-suicidal self-injury
- 4 November 2026
- Published by Springer Nature in Child and Adolescent Psychiatry and Mental Health
Open AccessLocal neural synchrony and suicidal ideation severity in adolescents with non-suicidal self-injury
- Open Access
- 1 November 2026
- Published by KEAI Publishing in Genes & Diseases
- Vol. 13 (6)
A novel chimeric RNA RPGR-EEF1A1 enhances autophagy by interaction with the small GTPase RAB37 in a GTP-dependent manner
- 1 November 2026
- Published by KEAI Publishing in Genes & Diseases
- Vol. 13 (6)
Open AccessA novel chimeric RNA RPGR-EEF1A1 enhances autophagy by interaction with the small GTPase RAB37 in a GTP-dependent manner
- Open Access
- 20 October 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (20)
Altered Intersubject Variability of Morphological Connectivity in Cerebral Small Vessel Disease and Its Associations With Gene Expression and Cell Types
Background: Cerebral small vessel disease (CSVD) is a heterogeneous disorder; however, interindividual variability in morphometric brain connectivity remains unclear, as does its association with gene expression. Methods: We enrolled 65 patients with CSVD and 35 healthy controls. Individual‐level morphometric brain networks were constructed from T1‐weighted magnetic resonance imaging, and intersubject variability of morphometric connectivity (IVMC) was quantified using a Kullback–Leibler divergence–based gray matter similarity measure. Group differences in IVMC and its associations with cognitive and clinical measures were examined. Partial least squares regression was applied to Allen Human Brain Atlas data to relate IVMC to gene expression, cell‐type specificity, and biological functions. Results: Compared with healthy controls, patients with CSVD showed globally increased IVMC ( P False Discovery Rate <0.05). IVMC in the sensorimotor and ventral attention networks was associated with poorer Auditory‐Verbal Learning Test performance. Partial least squares regression analysis revealed that IVMC‐related genes were enriched in neurodevelopmental and metabolic processes, whereas negatively weighted genes were associated with synaptic structure and glutamatergic signaling. Cell‐type analyses linked IVMC alterations primarily to neuronal and glial transcriptional signatures. Conclusions: CSVD is associated with elevated IVMC across multiple functional networks, with changes in specific networks linked to memory impairment. These alterations may be associated with genes involved in neurodevelopment, synaptic function, and diverse neuronal and glial cell types, providing new insights into the interindividual variability of brain networks and the neurophysiological mechanisms underlying CSVD.
- 20 October 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (20)
Open AccessAltered Intersubject Variability of Morphological Connectivity in Cerebral Small Vessel Disease and Its Associations With Gene Expression and Cell Types
Background: Cerebral small vessel disease (CSVD) is a heterogeneous disorder; however, interindividual variability in morphometric brain connectivity remains unclear, as does its association with gene expression. Methods: We enrolled 65 patients with CSVD and 35 healthy controls. Individual‐level morphometric brain networks were constructed from T1‐weighted magnetic resonance imaging, and intersubject variability of morphometric connectivity (IVMC) was quantified using a Kullback–Leibler divergence–based gray matter similarity measure. Group differences in IVMC and its associations with cognitive and clinical measures were examined. Partial least squares regression was applied to Allen Human Brain Atlas data to relate IVMC to gene expression, cell‐type specificity, and biological functions. Results: Compared with healthy controls, patients with CSVD showed globally increased IVMC ( P False Discovery Rate <0.05). IVMC in the sensorimotor and ventral attention networks was associated with poorer Auditory‐Verbal Learning Test performance. Partial least squares regression analysis revealed that IVMC‐related genes were enriched in neurodevelopmental and metabolic processes, whereas negatively weighted genes were associated with synaptic structure and glutamatergic signaling. Cell‐type analyses linked IVMC alterations primarily to neuronal and glial transcriptional signatures. Conclusions: CSVD is associated with elevated IVMC across multiple functional networks, with changes in specific networks linked to memory impairment. These alterations may be associated with genes involved in neurodevelopment, synaptic function, and diverse neuronal and glial cell types, providing new insights into the interindividual variability of brain networks and the neurophysiological mechanisms underlying CSVD.
- Open Access
- 7 October 2026
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 56, e320
Molecular mechanisms of electroconvulsive therapy modulates excitation–inhibition balance in major depression disorder
Background: The excitation–inhibition (E/I) imbalance is a major pathological characteristic of major depressive disorder (MDD). However, whether/how electroconvulsive therapy (ECT) modulates neuronal homeostasis or E/I balance in MDD and its molecular basis is still largely unknown. Methods: In this study, longitudinal rs-fMRI data from 46 patients with MDD receiving ECT and 46 healthy controls were included. The Hurst index was used to characterize the E/I balance, and mixed-effects model was constructed to assess the interactive effects of ECT on the Hurst index and functional connectivity (FC). Moreover, spatial correlation analyses were conducted by integrating cortical myelination pattern, glucose metabolism distribution, neurotransmitter density maps, and transcriptomic data to reveal the underlying molecular basis. Results: ECT significantly reduces the Hurst index in the middle cingulate cortex (MCC) and induces functional decoupling between the MCC and the posterior cingulate cortex. Furthermore, changes in the Hurst index were closely associated with cortical myelination, glucose metabolism, and the distribution maps of dopamine and histamine. Spatial transcriptomic association analysis revealed that genes regulating the effects of ECT on Hurst index or FC are specifically enriched in cell types such as excitatory neurons, astrocytes, and oligodendrocytes, and are primarily involved in biological processes including synaptic signal transduction, neuronal projection regulation, and glutamatergic synapses. Conclusion: These findings suggest that ECT may regulate the processes of myelin remodelling through neurons and glial cells by influencing the expression levels of relevant genes, thereby modulating the E/I balance and functional network activity in a synergistic manner to improve depressive symptoms.
- 7 October 2026
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 56, e320
Open AccessMolecular mechanisms of electroconvulsive therapy modulates excitation–inhibition balance in major depression disorder
Background: The excitation–inhibition (E/I) imbalance is a major pathological characteristic of major depressive disorder (MDD). However, whether/how electroconvulsive therapy (ECT) modulates neuronal homeostasis or E/I balance in MDD and its molecular basis is still largely unknown. Methods: In this study, longitudinal rs-fMRI data from 46 patients with MDD receiving ECT and 46 healthy controls were included. The Hurst index was used to characterize the E/I balance, and mixed-effects model was constructed to assess the interactive effects of ECT on the Hurst index and functional connectivity (FC). Moreover, spatial correlation analyses were conducted by integrating cortical myelination pattern, glucose metabolism distribution, neurotransmitter density maps, and transcriptomic data to reveal the underlying molecular basis. Results: ECT significantly reduces the Hurst index in the middle cingulate cortex (MCC) and induces functional decoupling between the MCC and the posterior cingulate cortex. Furthermore, changes in the Hurst index were closely associated with cortical myelination, glucose metabolism, and the distribution maps of dopamine and histamine. Spatial transcriptomic association analysis revealed that genes regulating the effects of ECT on Hurst index or FC are specifically enriched in cell types such as excitatory neurons, astrocytes, and oligodendrocytes, and are primarily involved in biological processes including synaptic signal transduction, neuronal projection regulation, and glutamatergic synapses. Conclusion: These findings suggest that ECT may regulate the processes of myelin remodelling through neurons and glial cells by influencing the expression levels of relevant genes, thereby modulating the E/I balance and functional network activity in a synergistic manner to improve depressive symptoms.
- Open Access
- 1 October 2026
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 32 (10) , e71159
The Role of Glymphatic Clearance in Affective Decision‐Making in Adolescents with Non‐Suicidal Self‐Injury
Background: Adolescents with non‐suicidal self‐injury (NSSI) frequently exhibit severe sleep disturbances and heterogeneous cognitive impairments, yet the underlying neurophysiological basis remains unclear. The glymphatic system, a sleep‐dependent macroscopic clearance network, is critical for metabolic waste removal and neurocognitive homeostasis. Therefore, this study aimed to investigate the physiological role of glymphatic function in linking sleep burden to distinct cognitive performances in adolescents with NSSI. Methods: We assessed 44 NSSI adolescents and 33 healthy controls (HCs). Using resting‐state functional magnetic resonance imaging (rs‐fMRI), glymphatic function was quantified by calculating the coupling strength between global blood‐oxygen‐level‐dependent (gBOLD) signals and cerebrospinal fluid (CSF) flow. To capture the heterogeneity in their cognitive profiles, we evaluated “hot” affective decision‐making via the Iowa Gambling Task (IGT) and “cold” executive function via the Wisconsin Card Sorting Test (WCST). Subjective sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI). Results: In the NSSI group, poorer sleep quality was positively correlated with stronger gBOLD‐CSF coupling ( r = 0.317, p = 0.036), and stronger gBOLD‐CSF coupling predicted better IGT performance, especially during the high‐load strategy phase (Block 3) ( r = 0.447, p = 0.002). Furthermore, glymphatic function fully mediated the relationship between sleep quality and affective decision‐making performance (indirect effect = 0.682, 95% CI [0.062, 1.515]). Interaction analyses confirmed this physiological‐behavioral coupling was disease‐specific (present only in NSSI; interaction p = 0.011) and domain‐specific (supporting “hot” affective cognition rather than “cold” executive function). Conclusions: In NSSI adolescents, sleep‐associated glymphatic upregulation reflects a stress‐induced compensatory response. This mechanism domain‐specifically preserves high‐load affective decision‐making against severe psychopathological stress. These findings highlight brain metabolic clearance as a novel physiological target for bolstering cognitive resilience in high‐risk youth.
- 1 October 2026
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 32 (10) , e71159
Open AccessThe Role of Glymphatic Clearance in Affective Decision‐Making in Adolescents with Non‐Suicidal Self‐Injury
Background: Adolescents with non‐suicidal self‐injury (NSSI) frequently exhibit severe sleep disturbances and heterogeneous cognitive impairments, yet the underlying neurophysiological basis remains unclear. The glymphatic system, a sleep‐dependent macroscopic clearance network, is critical for metabolic waste removal and neurocognitive homeostasis. Therefore, this study aimed to investigate the physiological role of glymphatic function in linking sleep burden to distinct cognitive performances in adolescents with NSSI. Methods: We assessed 44 NSSI adolescents and 33 healthy controls (HCs). Using resting‐state functional magnetic resonance imaging (rs‐fMRI), glymphatic function was quantified by calculating the coupling strength between global blood‐oxygen‐level‐dependent (gBOLD) signals and cerebrospinal fluid (CSF) flow. To capture the heterogeneity in their cognitive profiles, we evaluated “hot” affective decision‐making via the Iowa Gambling Task (IGT) and “cold” executive function via the Wisconsin Card Sorting Test (WCST). Subjective sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI). Results: In the NSSI group, poorer sleep quality was positively correlated with stronger gBOLD‐CSF coupling ( r = 0.317, p = 0.036), and stronger gBOLD‐CSF coupling predicted better IGT performance, especially during the high‐load strategy phase (Block 3) ( r = 0.447, p = 0.002). Furthermore, glymphatic function fully mediated the relationship between sleep quality and affective decision‐making performance (indirect effect = 0.682, 95% CI [0.062, 1.515]). Interaction analyses confirmed this physiological‐behavioral coupling was disease‐specific (present only in NSSI; interaction p = 0.011) and domain‐specific (supporting “hot” affective cognition rather than “cold” executive function). Conclusions: In NSSI adolescents, sleep‐associated glymphatic upregulation reflects a stress‐induced compensatory response. This mechanism domain‐specifically preserves high‐load affective decision‐making against severe psychopathological stress. These findings highlight brain metabolic clearance as a novel physiological target for bolstering cognitive resilience in high‐risk youth.
- Open Access
- 7 July 2026
- Published by Elsevier in Brain Research Bulletin
- Vol. 244, 112033
Regional Structural-Functional Coupling in Generalized Anxiety Disorder and Association with Neurotransmitter and Gene Signature
- 7 July 2026
- Published by Elsevier in Brain Research Bulletin
- Vol. 244, 112033
Open AccessRegional Structural-Functional Coupling in Generalized Anxiety Disorder and Association with Neurotransmitter and Gene Signature
- Open Access
- 2 July 2026
- Published by Springer Nature in BMC Medicine
- Vol. 24 (1)
A lesion-derived brain network of somatic symptoms for transdiagnostic individual application
Background: Somatic symptoms is an umbrella term that describes distressing somatic complaints occurring across a wide spectrum of diseases. However, their underlying neural mechanisms remain poorly understood. Elucidating their mechanisms could therefore benefit patients with diverse conditions. Methods: Using a recently validated lesion network mapping method and a large-scale healthy connectome database ( n = 652, recruited in Anhui Province, China), we identified a somatic network from brain lesions causing somatic symptoms. The lesion-derived network was validated using independent multimodal neuroimaging signatures of somatic symptoms and interoceptive processing. It was further characterized by transcriptomic, neurochemical, and cognitive meta-analytic mapping. We further assessed the therapeutic potential of the somatic network by quantifying its spatial convergence with empirically validated neuromodulation targets. Finally, to determine whether the group-level network can predict personalized symptom severity across diagnoses, we built a normative model of gray matter volume using Gaussian process regression based on 1,342 healthy controls from Anhui. This model was then used to generate personalized atrophy maps in 399 local somatic patients with anxiety, depression, schizophrenia and bipolar disorder. We then assessed whether individual atrophy volume within the somatic network was associated with somatic symptom severity. Results: We found that 21 heterogeneous lesions associated somatic symptoms occurred in many different brain locations but were characterized by a common brain network, with the hub region of the right insula and putamen. The somatic network demonstrated strong spatial alignment with multimodal somatic imaging abnormalities from 66 independent studies and interoceptive processing circuits from 69 task-fMRI studies. 11 effective brain stimulation targets were colocalization with the somatic network. In individual transdiagnostic patients, greater atrophy volume within the somatic network was significantly correlated with somatic symptom severity ( r = 0.182, p = 0.004), but not with anxiety or depression symptoms. Conclusions: These convergent findings establish a unified somatic network framework, advancing both mechanistic understanding and precision medicine applications.
- 2 July 2026
- Published by Springer Nature in BMC Medicine
- Vol. 24 (1)
Open AccessA lesion-derived brain network of somatic symptoms for transdiagnostic individual application
Background: Somatic symptoms is an umbrella term that describes distressing somatic complaints occurring across a wide spectrum of diseases. However, their underlying neural mechanisms remain poorly understood. Elucidating their mechanisms could therefore benefit patients with diverse conditions. Methods: Using a recently validated lesion network mapping method and a large-scale healthy connectome database ( n = 652, recruited in Anhui Province, China), we identified a somatic network from brain lesions causing somatic symptoms. The lesion-derived network was validated using independent multimodal neuroimaging signatures of somatic symptoms and interoceptive processing. It was further characterized by transcriptomic, neurochemical, and cognitive meta-analytic mapping. We further assessed the therapeutic potential of the somatic network by quantifying its spatial convergence with empirically validated neuromodulation targets. Finally, to determine whether the group-level network can predict personalized symptom severity across diagnoses, we built a normative model of gray matter volume using Gaussian process regression based on 1,342 healthy controls from Anhui. This model was then used to generate personalized atrophy maps in 399 local somatic patients with anxiety, depression, schizophrenia and bipolar disorder. We then assessed whether individual atrophy volume within the somatic network was associated with somatic symptom severity. Results: We found that 21 heterogeneous lesions associated somatic symptoms occurred in many different brain locations but were characterized by a common brain network, with the hub region of the right insula and putamen. The somatic network demonstrated strong spatial alignment with multimodal somatic imaging abnormalities from 66 independent studies and interoceptive processing circuits from 69 task-fMRI studies. 11 effective brain stimulation targets were colocalization with the somatic network. In individual transdiagnostic patients, greater atrophy volume within the somatic network was significantly correlated with somatic symptom severity ( r = 0.182, p = 0.004), but not with anxiety or depression symptoms. Conclusions: These convergent findings establish a unified somatic network framework, advancing both mechanistic understanding and precision medicine applications.
- Open Access
- 24 June 2026
- Published by Elsevier in Brain Stimulation
- Vol. 19 (4) , 103144
Effect of individualized high-definition Transcranial alternating current stimulation for suicidal ideation in depression: A randomized clinical trial
- 24 June 2026
- Published by Elsevier in Brain Stimulation
- Vol. 19 (4) , 103144
Open AccessEffect of individualized high-definition Transcranial alternating current stimulation for suicidal ideation in depression: A randomized clinical trial
- Open Access
- 15 May 2026
- Published by Wiley in Advanced Science
- Vol. 13 (45) , e75698
Inhibitory Decay and Supercritical Brain Dynamics During Sleep Deprivation
Sleep deprivation (SD) changes brain‐wide dynamics, but the circuit‐level perturbation that can generate this systems‐level shift remains unclear. We scanned 26 participants at seven time points across 36 h of continuous wakefulness and assessed criticality from resting‐state functional Magnetic Resonance Imaging (rs‐fMRI) blood‐oxygen‐level‐dependent (BOLD) signals using neuronal avalanche metrics (branching ratio and mean avalanche size). The branching ratio increased from 0.98 at baseline to 1.08 after 36 h, indicating a progressive shift from near‐critical to supercritical propagation. Interestingly, the shift was heterogeneous. Visual and sensorimotor networks showed the largest deviations, whereas the limbic network remained close to criticality. Criticality changes tracked accumulated subjective sleep pressure but were largely dissociated from psychomotor vigilance lapses. SD also reshaped functional network organization, with the functional connectivity (FC) degree distribution shifting toward more high‐degree nodes. In a recurrent excitatory–inhibitory network model, gamma‐band power provided an interpretable proxy for effective gain and inhibitory control. Using this proxy, selectively reducing inhibitory efficacy was sufficient to capture the direction of the near‐critical‐to‐supercritical drift and a limbic‐like resilience pattern, supporting inhibitory decay as a plausible candidate circuit‐level mechanism linking SD to large‐scale propagation instability.
- 15 May 2026
- Published by Wiley in Advanced Science
- Vol. 13 (45) , e75698
Open AccessInhibitory Decay and Supercritical Brain Dynamics During Sleep Deprivation
Sleep deprivation (SD) changes brain‐wide dynamics, but the circuit‐level perturbation that can generate this systems‐level shift remains unclear. We scanned 26 participants at seven time points across 36 h of continuous wakefulness and assessed criticality from resting‐state functional Magnetic Resonance Imaging (rs‐fMRI) blood‐oxygen‐level‐dependent (BOLD) signals using neuronal avalanche metrics (branching ratio and mean avalanche size). The branching ratio increased from 0.98 at baseline to 1.08 after 36 h, indicating a progressive shift from near‐critical to supercritical propagation. Interestingly, the shift was heterogeneous. Visual and sensorimotor networks showed the largest deviations, whereas the limbic network remained close to criticality. Criticality changes tracked accumulated subjective sleep pressure but were largely dissociated from psychomotor vigilance lapses. SD also reshaped functional network organization, with the functional connectivity (FC) degree distribution shifting toward more high‐degree nodes. In a recurrent excitatory–inhibitory network model, gamma‐band power provided an interpretable proxy for effective gain and inhibitory control. Using this proxy, selectively reducing inhibitory efficacy was sufficient to capture the direction of the near‐critical‐to‐supercritical drift and a limbic‐like resilience pattern, supporting inhibitory decay as a plausible candidate circuit‐level mechanism linking SD to large‐scale propagation instability.